The University of Dundee's Professor Jill Belch, who has been named a CBE in the New Years Honours list.

A world-leading expert in stroke treatment from the University of Dundee believes that specialised ambulances could prevent ...

We will continue to offer all Library services as usual. There are also study spaces available during the day in the following locations: What's happening? The Main Library will be without heating for ...

Anatomical examination – where medical, dental and science students learn about the structure and function of the human body. Education and training - to train healthcare professionals, usually those ...

Jill Belch is a Professor of Vascular Medicine at the University of Dundee, UK, where until January 2016 she was the Research Dean then Co-Dean of the Medical School. She was also NHS Tayside R&D ...

Details for the Humanitarian scholarshipHome Corporate Information Key facts Key facts for the Humanitarian scholarship Details for the Humanitarian scholarship ...

We are always around and using technology. We often use it for studying and communicating. It can distract us in various ways. For example, by hearing a message or getting a notification. When you ...

Professor Jill Belch, from the University of Dundee’s School of Medicine, says that youngsters are sustaining irreparable damage to their lungs due to the inhalation of harmful particulates emitted by ...

Home Corporate Information Data Scottish Government Urban Rural Classification Postcode Lookup Lists all postcodes in Scotland and their urban/rural category Updated on 2 August 2022 ...

Phishing emails may also come from compromised @dundee.ac.uk accounts, you should report these in the same way. If you are using the Classic Ribbon, click the Report Message menu button and select ...

Protein degrader molecules are heralding a revolution in drug discovery, with more than 50 drugs of this type currently being tested in clinical trials for patients with diseases for which no other ...

A patient from Dundee has become the first patient in Europe on a global trial to be given a personalised cancer therapy (Individualised Neoantigen Therapy - INT) for their type of cancer, using ...